Dipeptidyl peptidase IV: serum activity and expression on lymphocytes in different hematological malignancies

References

• Zelenetz AD, Abramson JS, Advani RH, et al. Non Hodgkin's lymphomas. J Natl Compr Canc Netw 2011;9:484–560.
   PubMed Web of Science ®Google Scholar
• Mani H, Jaffe ES. Hodgkin's lymphoma: an update on its biology with newer insights into classification. Clin Lymphoma Myeloma 2009;9:206–216.
   PubMedGoogle Scholar
• McGregor S, McNeer J, Gurbuxani S. Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemia. Semin Diagn Pathol 2012;29:2–11.
   PubMed Web of Science ®Google Scholar
• Roboz GJ. Novel approaches to the treatment of acute myeloid leukemia. Hematology Am Soc Hematol Educ Program 2011:43–50.
   Google Scholar
• Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005;352:804–815.
   PubMed Web of Science ®Google Scholar
• Palumbo A, Anderson K. Multiple myeloma. N Engl J Med 2011;364:1046–1060.
   PubMed Web of Science ®Google Scholar
• Soutar R, Lucraft H, Jackson G, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol 2004;124:717–726.
   PubMed Web of Science ®Google Scholar
• Lambeir AM, Durinx C, Scharpé S, et al. Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit Rev Clin Lab Sci 2003;40:209–294.
   PubMed Web of Science ®Google Scholar
• Boonacker E, Van Noorden CJF. The multifunctional or moonlighting protein CD26/DPPIV. Eur J Cell Biol 2003;82:53–73.
   PubMed Web of Science ®Google Scholar
• Cordero OJ, Salgado FJ, Nogueira M. On the origin of serum CD26 and its altered concentration in cancer patients. Cancer Immunol Immunother 2009;58:1723–1747.
   PubMed Web of Science ®Google Scholar
• Kikkawa F, Kajiyama H, Shibata K, et al. Dipeptidyl peptidase IV in tumor progression. Biochim Biophys Acta 2005;1751:45–51.
   PubMed Web of Science ®Google Scholar
• Havre PA, Abe M, Urasaki Y, et al. The role of CD26/dipeptidyl peptidase IV in cancer. Front Biosci 2008;13:1634–1645.
   PubMed Web of Science ®Google Scholar
• Cordero OJ, Imbernon M, Chiara LD, et al. Potential of soluble CD26 as a serum marker for colorectal cancer detection. World J Clin Oncol 2011;2:245–261.
   Google Scholar
• Fukasawa K, Harada M, Komatsu M, et al. Serum dipeptidyl peptidase (DPP) IV activities in oral cancer patients. Int J Oral Surg 1982;11:246–250.
   PubMedGoogle Scholar
• Goscinski MA, Suo ZH, Nesland JM, et al. Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines. APMIS 2008;116:823–831.
   PubMed Web of Science ®Google Scholar
• Wilson MJ, Ruhland AR, Quast BJ, et al. Dipeptidylpeptidase IV activities are elevated in prostate cancers and adjacent benign hyperplastic glands. J Androl 2000;21:220–226.
   PubMed Web of Science ®Google Scholar
• Wesley UV, Albino AP, Tiwari S, et al. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J Exp Med 1999;190:311–322.
   PubMed Web of Science ®Google Scholar
• Miyake Y, Aratake Y, Sakaguchi T, et al. Examination of CD26/DPPIV, p53, and PTEN expression in thyroid follicular adenoma. Diagn Cytopathol 2012;40:1047–1053.
   PubMed Web of Science ®Google Scholar
• Erić-Nikolić A, Matić IZ, Ðorđević M, et al. Serum DPPIV activity and CD26 expression on lymphocytes in patients with benign or malignant breast tumors. Immunobiology 2011;216:942–946.
   PubMed Web of Science ®Google Scholar
• Matić IZ, Đorđić M, Grozdanić N, et al. Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligo. BMC Immunol 2012;13:48.
   PubMedGoogle Scholar
• Jarmolowska B, Bielikowicz K, Iwan M, et al. Serum activity of dipeptidyl peptidase IV (DPPIV; EC 3.4.14.5) in breast-fed infants with symptoms of allergy. Peptides 2007;28:678–682.
   PubMed Web of Science ®Google Scholar
• Kojima K, Mihara R, Sakai T, et al. Serum activities of dipeptidyl-aminopeptidase II and dipeptidyl-aminopeptidase IV in tumor-bearing animals and in cancer patients. Biochem Med Metab Biol 1987;37:35–41.
   PubMedGoogle Scholar
• Miyagaki T, Sugaya M, Suga H, et al. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels. J Eur Acad Dermatol Venereol 2013;27:19–24.
   PubMed Web of Science ®Google Scholar
• Jones D, Dang NH, Duvic M, et al. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol 2001;115:885–892.
   PubMed Web of Science ®Google Scholar
• Cro L, Morabito F, Zucal N, et al. CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL. Hematol Oncol 2009;27:140–147.
   PubMed Web of Science ®Google Scholar
• de Andrade CF, Bigni R, Pombo-de-Oliveira MS, et al. CD26/DPPIV cell membrane expression and DPPIV activity in plasma of patients with acute leukemia. J Enzyme Inhib Med Chem 2009;24:708–714.
   PubMed Web of Science ®Google Scholar
• Bauvois B, De Meester I, Dumont J, et al. Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia. Br J Cancer 1999;79:1042–1048.
   PubMed Web of Science ®Google Scholar
• Kondo S, Kotani T, Tamura K, et al. Expression of CD26/dipeptidyl peptidase IV in adult T cell leukemia/lymphoma (ATLL). Leuk Res 1996;20:357–363.
   PubMed Web of Science ®Google Scholar
• Tsuji T, Sugahara K, Tsuruda K, et al. Clinical and oncological implications in epigenetic down-regulation of CD26/dipeptidyl peptidase IV in adult T-cell leukemia cells. Int J Hematol 2004;80:254–260.
   PubMed Web of Science ®Google Scholar
• Shao H, Yuan CM, Xi L, et al. Minimal residual disease detection by flow cytometry in adult T-cell leukemia/lymphoma. Am J Clin Pathol 2010;133:592–601.
   PubMed Web of Science ®Google Scholar
• Elgün S, Keskinege A, Akan H, et al. Serum dipeptidyl peptidase IV activity correlates with the T-cell CD26 antigen. Clin Chem Lab Med 1999;37:839–840.
   PubMed Web of Science ®Google Scholar
• Carbone A, Gloghini A, Zagonel V, et al. The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias. Blood 1995;86:4617–4626.
   PubMed Web of Science ®Google Scholar